OPTN/SRTR 2022 Annual Data Report: COVID-19

Jonathan M. Miller, Yoon Son Ahn, Allyson Hart, Dorry L. Segev, David P. Schladt, Kathryn T. Livelli, Kelsi A. Lindblad, Ajay K. Israni, Jon J. Snyder

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

This chapter updates the COVID-19 chapter from the 2021 Annual Data Report with trends through November 12, 2022, and introduces trends in recovery and use of organs from donors with a positive COVID-19 test. Posttransplant mortality and graft failure, which remained a concern in all organs at the last report due to the Omicron variant wave, have returned to lower levels in the most recent available data through November 2022. Use of organs from donors with a positive COVID-19 test has grown, particularly after the first year of the pandemic. Mortality due to COVID-19 should continue to be monitored, but most other measures have sustained their recovery and may now be responding more to changes in policy than to ongoing concerns with COVID-19.

Original languageEnglish (US)
Pages (from-to)S489-S533
JournalAmerican Journal of Transplantation
Volume24
Issue number2
DOIs
StatePublished - Feb 2024
Externally publishedYes

Keywords

  • COVID-19
  • solid organ transplant
  • transplant outcomes
  • waitlist mortality

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'OPTN/SRTR 2022 Annual Data Report: COVID-19'. Together they form a unique fingerprint.

Cite this